Candel Therapeutics Inc. (CADL)
NASDAQ · Healthcare
Candel Therapeutics Inc. annual/quarterly shareholder equity history from 2020 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Candel Therapeutics Inc. shareholder equity for the quarter ending December 31, 2022 were 47.7M, a 25.61% decrease year-over-year.
- Candel Therapeutics Inc. shareholder equity for 2022 were 47.7M, a 25.61% decrease from 2021.
- Candel Therapeutics Inc. shareholder equity for 2021 were 64.1M, a 372.21% decrease from 2020.
- Candel Therapeutics Inc. shareholder equity for 2020 were -23.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Candel Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $48 |
| 2021 | $64 |
| 2020 | $-24 |
| Candel Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2022-12-31 | $48 |
| 2021-12-31 | $64 |
| 2020-12-31 | $-24 |
Candel Therapeutics Inc. Shareholder Equity — FAQ
Candel Therapeutics Inc. (CADL) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CADL's shareholder equity history?
The chart and table above show Candel Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.